<DOC>
	<DOCNO>NCT00554580</DOCNO>
	<brief_summary>The investigator hypothesise CPAP + pharmaceutical treatment , compare pharmaceutical treatment alone , improve respiratory hemodynamic status patient H2 inclusion time decrease rate death tracheal intubation first 48 hour .</brief_summary>
	<brief_title>Continuous Positive Airway Pressure Acute Pulmonary Edema</brief_title>
	<detailed_description>Patients include home inform consent emergency medical team transport follow 2 hour cardiac intensive care unit treatment purchase well . Randomization process do previously envelop ; group A : pharmaceutical treatment alone , B pharmaceutical plus CPAP . Medical treatment include furosemide nitroglycerin ( continuous perfusion bolus ) , inotropes need , specific treatment require ( ex : anti antiarrhythmic drug ) . Doses free , adapt clinical response respiratory hemodynamic distress . CPAP passive high flow venturi system device aliment hyperbaric oxygen . FiO2 control adapt pulsed oxygen saturation . PEP must initially celled least 7.5 cmH2O increase 10 well tolerate .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<mesh_term>Edema</mesh_term>
	<mesh_term>Dyspnea</mesh_term>
	<mesh_term>Pulmonary Edema</mesh_term>
	<criteria>age &gt; 18 acute respiratory insufficiency hypoxia air KILLIP score 2 4 absence know ST elevation acute coronary syndrome accept inform consent . age &lt; 18 immediate intubation criterion ( bradypnea , coma status ) refractory shock</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>continuous positive airway pressure</keyword>
	<keyword>outcome measure</keyword>
	<keyword>clinical trial</keyword>
</DOC>